AI assistant
Vanda Pharmaceuticals Inc. — Director's Dealing 2015
Sep 15, 2015
33390_dirs_2015-09-15_07517ccf-6937-48f7-91a0-c0b6daadc331.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Vanda Pharmaceuticals Inc. (VNDA)
CIK: 0001347178
Period of Report: 2015-09-14
Reporting Person: Gulino Richard L. (SVP & General Counsel)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-09-14 | Employee Stock Option (Right to Buy) | $13.26 | A | 150000 | Acquired | 2025-09-13 | Common Stock (150000) | Direct |
| 2015-09-14 | Restricted Stock Unit | $ | A | 50000 | Acquired | Common Stock (50000) | Direct |
Footnotes
F1: This option vests and becomes exercisable with respect to 1/4 of the shares subject to this option on September 14, 2016 (the "Initial Vesting Date"), provided Reporting Person remains continuously employed by the Issuer through the Initial Vesting Date, and with respect to the remaining 3/4 of the shares in 36 equal monthly installments beginning on October 14, 2016, provided Reporting Person remains continuously employed by the Issuer through each monthly vesting date.
F2: Each Restricted Stock Unit ("RSU") represents a contingent right to receive a share of the Issuer's common stock.
F3: The RSUs shall vest in four (4) equal annual installments beginning January 1, 2017, provided Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissable Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest.
F4: Not applicable.